Navigating to the most promising directions amid complex fields of vaccine development: a chlamydial case study

References

• Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PloS One. 2015;10(12):e0143304.
   PubMed Web of Science ®Google Scholar
• Owusu-Edusei K Jr, Chesson HW, Gift TL, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40(3):197–201.
   PubMed Web of Science ®Google Scholar
• Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol. 2005;5(2):149.
   PubMed Web of Science ®Google Scholar
• Burton MJ, Mabey DC. The global burden of trachoma: a review. PLoS Negl Trop Dis. 2009;3(10):e460.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197–2223.
   PubMed Web of Science ®Google Scholar
• Gottlieb SL, Low N, Newman LM, et al. Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines. Vaccine. 2014;32(14):1527–1535.
   PubMed Web of Science ®Google Scholar
• Brunham RC, Rappuoli R. Chlamydia trachomatis control requires a vaccine. Vaccine. 2013;31(15):1892–1897.
   PubMed Web of Science ®Google Scholar
• Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis. 2009;36(8):478–489.
   PubMed Web of Science ®Google Scholar
• Longbottom D, Livingstone M. Vaccination against chlamydial infections of man and animals. Vet J. 2006;171(2):263–275.
   PubMed Web of Science ®Google Scholar
• Rockey DD, Wang J, Lei L, et al. Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev Vaccines. 2009;8(10):1365–1377.
   PubMed Web of Science ®Google Scholar
• Vasilevsky S, Greub G, Nardelli-Haefliger D, et al. Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research. Clin Microbiol Rev. 2014;27(2):346–370.
   PubMed Web of Science ®Google Scholar
• de la Maza LM, Zhong G, Brunham RC. Update in Chlamydia trachomatis vaccinology. Clin Vaccin Immunol. 2017;24(4):1-25.
   PubMedGoogle Scholar
• Phillips S, Quigley BL, Timms P. Seventy years of Chlamydia vaccine research–limitations of the past and directions for the future. Front Microbiol. 2019;10(70):1-18.
   Google Scholar
• Farris CM, Morrison RP. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect Immun. 2011;79(3):986–996.
   PubMed Web of Science ®Google Scholar
• Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun. 2002;70(6):2741–2751.
   PubMed Web of Science ®Google Scholar
• Tang FF, Huang YT, Chang HL, et al. Further studies on the isolation of the trachoma virus. Acta Virol. 1958;2(3):164–170.
   PubMedGoogle Scholar
• T’ang FF, Chang HL, Huang Y. Studies on the etiology of trachoma with special reference to isolation of the virus in chick embryo. Chin Med J (Engl). 1957;75(6):429–447.
   Google Scholar
• Mabey DC, Hu V, Bailey RL, et al. Towards a safe and effective chlamydial vaccine: lessons from the eye. Vaccine. 2014;32(14):1572–1578.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269.
   PubMed Web of Science ®Google Scholar
• Grayston JT, Wang S. New knowledge of chlamydiae and the diseases they cause. J Infect Dis. 1975;132(1):87–105.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgens JP, et al. Introduction to meta-analysis. Chichester, West Sussex: John Wiley & Sons, Ltd; 2009.
   Google Scholar
• Bommana S, Walker E, Desclozeaux M, et al. Humoral immune response against two surface antigens of Chlamydia pecorum in vaccinated and naturally infected sheep. PloS One. 2017;12(11):e0188370.
   PubMed Web of Science ®Google Scholar
• Higgins JG, S, editor. Cochrane handbook for systematic reviews of interventions. Chichester, West Sussex: John Wiley & Sons Ltd; 2008.
   Google Scholar
• Fairley SJ, Singh SR, Yilma AN, et al. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine. Int J Nanomedicine. 2013;8:2085.
   PubMed Web of Science ®Google Scholar
• Koroleva EA, Kobets NV, Shcherbinin DN, et al. Chlamydial type III secretion system needle protein induces protective immunity against Chlamydia muridarum intravaginal infection. Biomed Res Int. 2017;2017. DOI:10.1155/2017/3865802
   Web of Science ®Google Scholar
• Bandholtz L, Kreuger M, Svanholm C, et al. Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae. Clin Exp Immunol. 2002;130(3):393–403.
   PubMed Web of Science ®Google Scholar
• Hedges LV. Distribution theory for glass’s estimator of effect size and related estimators. J Educ Stat. 1981;6(2):107–128.
   Google Scholar
• Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:3.
   Web of Science ®Google Scholar
• Team RC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.
   Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Egger M. Regression methods to detect publication and other bias in meta-analysis. In: Rothstein HR, Sutton AJ, Borenstein M, editors. Publication bias in meta-analysis: prevention, assessment and adjustments. Chichester, West Sussex: John Wiley & Sons; 2005. p. 99–110.
   Google Scholar
• Lu CX, Zeng H, Li ZH, et al. Protective immunity against mouse upper genital tract pathology correlates with high IFN gamma but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway. Vaccine. 2012 Jan;30(2):475–485. PubMed PMID: WOS:000299971800051.
   PubMed Web of Science ®Google Scholar
• Jiang X, Shen C, Rey-Ladino J, et al. Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect Immun. 2008;76(6):2392–2401.
   PubMed Web of Science ®Google Scholar
• Stary G, Olive A, Radovic-Moreno AF, et al. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science. 2015; 348(6241):aaa8205-1-aaa8205-14.
   PubMed Web of Science ®Google Scholar
• Whittum-Hudson JA, An -L-L, Saltzman WM, et al. Oral immunization with an anti–idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection. Nat Med. 1996;2(10):1116.
   PubMed Web of Science ®Google Scholar
• Igietseme JU, Murdin A. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infect Immun. 2000 Dec;68(12):6798–6806. PubMed PMID: WOS:000167020000040.
   PubMed Web of Science ®Google Scholar
• Lunn T, Munks S, Carver S. The impacts of timber harvesting on stream biota–an expanding field of heterogeneity. Biol Conserv. 2017;213:154–166.
   Web of Science ®Google Scholar
• Hofmann SG, Sawyer AT, Witt AA, et al. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol. 2010;78(2):169.
   PubMed Web of Science ®Google Scholar
• Shaw AC, Vandahl BB, Larsen MR, et al. Characterization of a secreted Chlamydia protease. Cell Microbiol. 2002;4(7):411–424.
   PubMed Web of Science ®Google Scholar
• Zhong G, Fan P, Ji H, et al. Identification of a chlamydial protease–like activity factor responsible for the degradation of host transcription factors. J Exp Med. 2001;193(8):935–942.
   PubMed Web of Science ®Google Scholar
• Chaganty BK, Murthy AK, Evani SJ, et al. Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge. Vaccine. 2010;28(11):2323–2329.
   PubMed Web of Science ®Google Scholar
• Li W, Guentzel MN, Seshu J, et al. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach. Clin Vaccine Immunol. 2007;14(12):1537–1544.
   PubMedGoogle Scholar
• Tan M, Sütterlin C. The Chlamydia protease CPAF: caution, precautions and function. Pathog Dis. 2014;72(1):7–9.
   PubMed Web of Science ®Google Scholar
• Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun. 1981;31(3):1161–1176.
   PubMed Web of Science ®Google Scholar
• Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 2003;67(4):593–656.
   PubMed Web of Science ®Google Scholar
• Sun G, Pal S, Sarcon AK, et al. Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol. 2007;189(17):6222–6235.
   PubMed Web of Science ®Google Scholar
• Hafner L, Beagley K, Timms P. Chlamydia trachomatis infection: host immune responses and potential vaccines. Mucosal Immunol. 2008;1(2):116.
   PubMed Web of Science ®Google Scholar
• Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Nat Acad Sci. 1993;90(9):3998–4002.
   PubMed Web of Science ®Google Scholar
• Beatty WL, Belanger TA, Desai AA, et al. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun. 1994;62(9):3705–3711.
   PubMed Web of Science ®Google Scholar
• Leonhardt RM, Lee S-J, Kavathas PB, et al. Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis. Infect Immun. 2007;75(11):5105–5117.
   PubMed Web of Science ®Google Scholar
• Pal S, Tifrea DF, Follmann F, et al. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge. Vaccine. 2017;35(13):1705–1711.
   PubMed Web of Science ®Google Scholar
• Pal S, Favaroni A, Tifrea DF, et al. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge. Vaccine. 2017;35(19):2543–2549.
   PubMed Web of Science ®Google Scholar
• Cheng C, Pal S, Tifrea D, et al. A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge. Microbes Infect. 2014;16(3):244–252.
   PubMed Web of Science ®Google Scholar
• Cheng C, Bettahi I, Cruz-Fisher MI, et al. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin. Vaccine. 2009;27(44):6239–6246.
   PubMed Web of Science ®Google Scholar
• Chang HL, Chin HY, Wang KC. Experimental studies on trachoma vaccine in monkeys. Chin Med J (Engl). 1964;83(11):755–762. PubMed PMID: WOS:A19646117900006.
   Web of Science ®Google Scholar
• Collier L, Blyth W. Immunogenicity of experimental trachoma vaccines in baboons: II. Experiments with adjuvants, and tests of cross-protection. Epidemiol Infect. 1966;64(4):529–544.
   Google Scholar
• Bulir DC, Liang S, Lee A, et al. Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge. Vaccine. 2016 Jul;34(34):3979–3985. PubMed PMID: WOS:000380604000011.
   PubMed Web of Science ®Google Scholar
• Brunham R, Kuo C, Cles L, et al. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun. 1983;39(3):1491–1494.
   PubMed Web of Science ®Google Scholar
• Darville T, Hiltke TJ. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis. 2010;201(S2):S114–S125.
   PubMedGoogle Scholar
• Sharma J, Bosnic AM, Piper JM, et al. Human antibody responses to a Chlamydia-secreted protease factor. Infect Immun. 2004;72(12):7164–7171.
   PubMed Web of Science ®Google Scholar
• Sharma J, Dong F, Pirbhai M, et al. Inhibition of proteolytic activity of a chlamydial proteasome/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis. Infect Immun. 2005;73(7):4414–4419.
   PubMed Web of Science ®Google Scholar
• Starnbach MN. Action needed on Chlamydia vaccines. Trends Microbiol. 2018;26(8):639–640.
   PubMed Web of Science ®Google Scholar
• Abraham S, Juel HB, Bang P, et al. Safety and immunogenicity of the Chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2019;19(10):1091–1100.
   Web of Science ®Google Scholar
• Olsen AW, Follmann F, Erneholm K, et al. Protection against Chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein. J Infect Dis. 2015;212(6):978–989.
   PubMed Web of Science ®Google Scholar
• Lorenzen E, Follmann F, Boje S, et al. Intramuscular priming and intranasal boosting induce strong genital immunity through secretory IgA in minipigs infected with Chlamydia trachomatis. Front Immunol. 2015 Dec;6(628). PubMed PMID: WOS:000366842500001. DOI:10.3389/fimmu.2015.00528
   PubMedGoogle Scholar
• Boje S, Olsen AW, Erneholm K, et al. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-gamma(+) CMI responses protects against a genital infection in minipigs. Immunol Cell Biol. 2016 Feb;94(2):185–195. PubMed PMID: WOS:000369694100012.
   PubMed Web of Science ®Google Scholar
• Kuczkowska K, Myrbraten I, Overland L, et al. Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization. Plos One. 2017 May;12(5):e0176401. PubMed PMID: WOS:000400647000050.
   PubMed Web of Science ®Google Scholar
• Olsen AW, Lorenzen EK, Rosenkrands I, et al. Protective effect of vaccine promoted neutralizing antibodies against the intracellular pathogen Chlamydia trachomatis. Front Immunol. 2017 Dec;8. PubMed PMID: WOS:000417588700001. DOI:10.3389/fimmu.2017.01652
   Web of Science ®Google Scholar
• Wern JE, Sorensen MR, Olsen AW, et al. Simultaneous subcutaneous and intranasal administration of a CAF01-adjuvanted Chlamydia vaccine elicits elevated IgA and protective Th1/Th17 responses in the genital tract. Front Immunol. 2017 May;8. PubMed PMID: WOS:000401473700001. DOI:10.3389/fimmu.2017.00569
   PubMed Web of Science ®Google Scholar
• Gottlieb SL, Deal CD, Giersing B, et al. The global roadmap for advancing development of vaccines against sexually transmitted infections: update and next steps. Vaccine. 2016;34(26):2939–2947.
   PubMed Web of Science ®Google Scholar
• Burton DR. Advancing an HIV vaccine; advancing vaccinology. Nat Rev Immunol. 2019;19(2):77–78.
   PubMed Web of Science ®Google Scholar
• Buendia AJ, Ortega N, Caro MR, et al. B cells are essential for moderating the inflammatory response and controlling bacterial multiplication in a mouse model of vaccination against Chlamydophila abortus infection. Infect Immun. 2009 Nov;77(11):4868–4876. PubMed PMID: WOS:000270885800018.
   PubMed Web of Science ®Google Scholar
• Longbottom D, Sait M, Livingstone M, et al. Genomic evidence that the live Chlamydia abortus vaccine strain 1B is not attenuated and has the potential to cause disease. Vaccine. 2018;36(25):3593–3598.
   PubMed Web of Science ®Google Scholar
• Caro MR, Buendia AJ, Ortega N, et al. Influence of the Th2 immune response established by Nippostrongylus brasiliensis infection on the protection offered by different vaccines against Chlamydophila abortus infection. Vet Res Commun. 2005 Mar;29:51–59. PubMed PMID: WOS:000229482500006.
   PubMed Web of Science ®Google Scholar